YY2 and neoplasm: YY2 competes with YY1 to bind to SLC7A11 promoter and regulates it antagonistically, resulting in the opposite regulation on glutathione synthesis, ferroptosis, and tumor progression, indicating that YY2/YY1 homeostasis is crucial for maintaining redox homeostasis in tumors.